Jung HA, Park S, Choi YL, Lee SH, et al. Continuation of Pembrolizumab with Additional Chemotherapy after Progression with PD-1/PD-L1 Inhibitor Monotherapy in Patients with Advanced NSCLC: A Randomized, Placebo-Controlled Phase II Study. Clin Cancer Res 2022;28:2321-2328.
PMID: 35101883